Stay updated with breaking news from Bio Techne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rhenman & Partners Asset Management AB reduced its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 38.9% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 55,000 shares of the biotechnology company’s stock after selling 35,000 shares during the […]
Exploring the Financial Strength, Profitability, and Growth Metrics of Bio-Techne Corp (TECH)
Bio-Techne (NASDAQ:TECH – Get Free Report) and AVROBIO (NASDAQ:AVRO – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, dividends, profitability and institutional ownership. Profitability This table compares Bio-Techne and AVROBIO’s net margins, return […]
Benchmark reissued their buy rating on shares of Bio-Techne (NASDAQ:TECH – Free Report) in a report issued on Friday, Benzinga reports. The firm currently has a $120.00 price target on the biotechnology company’s stock. Other equities analysts also recently issued reports about the stock. Robert W. Baird cut their price target on shares of Bio-Techne […]
Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 26,662 shares of the biotechnology company’s stock after acquiring an additional 129 shares during the quarter. […]